A novel machine learning version of the Opioid Risk Tool provides high precision screening for opioid use disorder in chronic pain patients.

There is a modest, but significant association between greater use of generative artificial intelligence and greater depressive symptoms.

The tablet-based TabCAT tool demonstrates strong convergent validity with traditional tests for early-onset Alzheimer disease (EOAD).

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.

Functional impairment and high healthcare utilization serve as key indicators for mortality risk among older adults living in structured housing environments.

After the CDC narrowed vaccine recommendations, many doctors say they will look to the American Academy of Pediatrics for vaccine guidance.

Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and reducing dementia risk.

A 6-month tailored weight loss program helps US veterans with serious mental illness achieve significant weight reduction.

A significant amount of psychological distress can occur in a considerable portion of women undergoing an unscheduled cesarean delivery.

Serum brain-derived neurotrophic factor levels were positively associated with the severity of depressive symptoms in patients with asthma. HealthDay News — Brain-derived neurotrophic factor (BDNF) is ...